Septic Shock Induced by Group a Streptococcal Infection: Clinical and Therapeutic Aspects

References

• Ispahani P, Donald F E, Aveline A JD. Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated. J Infect 1988; 16: 37–46
   PubMed Web of Science ®Google Scholar
• Martin P R, Høiby E A. Streptococcal serogroup A epidemic in Norway 1987–1988. Scand J Infect Dis 1990; 22: 421–429
   PubMed Web of Science ®Google Scholar
• Strömberg A, Romanus V, Burman L G. Outbreak of group A streptococcal bacteremia in Sweden. An epidemiological and clinical study. J Infect Dis 1991; 164: 595–598
   PubMed Web of Science ®Google Scholar
• Johnson L P, L'Italien J J, Schlievert P M. Streptococcal pyogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B. Mol Gen Genet 1986; 203: 354–356
   PubMedGoogle Scholar
• Cone L A, Voodard D R, Schlievert P M, Tomory G S. Clinical and bacteriological observations of a toxic-shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317: 146–149
   PubMed Web of Science ®Google Scholar
• Stevens D L, Tanner M H, Winship J, Swarts R, Ries K M, Schlievert P M, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl J Med 1989; 321: 1–7
   PubMed Web of Science ®Google Scholar
• Köhler W. Streptococcal toxic shock syndrome. Zentralbl Mikrobiol 1990; 272: 257–264
   Google Scholar
• Holm S E, Norrby A, Bergholm A-M, Norgren M. Aspects of the pathogenesis in serious group A streptococcal infections. J Infect Dis 1992; 166: 31–37
   PubMedGoogle Scholar
• Kühnemund O, Havlicek J, Knöll H, Sjöquist J, Köhler W. Interaction of group A streptococcal M protein with fibrinogen. Acta Pathol Microbiol Scand 1985; 93: 201–203
   Google Scholar
• Ipsen J. A standard for the anti-streptolysin 0 of human serum and its practical application. Acta Pathol Microbiol Scand 1944; 21: 203–213
   Google Scholar
• Nelson J, Ayob E M, Wannamaker L W. Streptococcal antideoxyribonuclease B: Microtechnique determination. J Lab Clin Med 1968; 71: 867–873
   PubMedGoogle Scholar
• Edwards J D, Brown G CS, Nightingale P, Slater R M, Faragher E B. Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 1989; 17: 1098–1103
   PubMed Web of Science ®Google Scholar
• Martin C, Saux P, Eon B, Aknin P, Gouin F. Septic chock: a goal- directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990; 34: 413–417
   PubMedGoogle Scholar
• Stegmayr B, Cedergren B, Nilsson T, Lindqvist B, Sondell K, Lindström S. On the use of liquid stored or cryoprecipitate- poor plasma in plasma exchange. An alternative to fresh frozen plasma. Immune and metabolic aspects of therapeutic blood purification systems. Karger, Basel 1986; 117–121, Proc Int Symp Trondheim 1985.
   Google Scholar
• Higgins T L. Pharmacotherapy of circulatory shock. Dis Mon 1987; 33(6): 309–361
   Google Scholar
• Goris R JA. Multi-organ failure. Arch Surg 1985; 120: 1109–1115
   PubMed Web of Science ®Google Scholar
• Gårdlund B. Prognostic evaluation in meningococcal disease. A retrospective study of 115 cases. Intensive Care Med 1986; 12: 302–307
   PubMed Web of Science ®Google Scholar
• Dominioni L, Dionigi R, Zanello M, Monico R, Cremaschi R, Dionigi R, Ballabio A, Massa M, Comelli M, Dal Ri P, Pisata P. Sepsis score and acute-phase protein response as predictors of outcome in septic surgical patients. Arch Surg 1987; 122: 141–146
   PubMedGoogle Scholar
• Smithies M N, Cameron J S. Can we predict outcome in acute renal failure. Nephron 1989; 51: 297–300
   PubMed Web of Science ®Google Scholar
• Maher E R, Robinson K N, Scoble J E, Farrimond J G, Browne D RG, Sweny P, Moorhead J F. Prognosis of critically-ill patients with acute renal failure: Apache II score and other predictive factors. Q J Med 1989; 72: 857–866
   PubMedGoogle Scholar
• Fast D J, Schlievert P H, Nelson R D. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 1989; 57: 291–294
   PubMedGoogle Scholar
• Ottosson J R. Experimental septic shock. Pathophysiology and treatment of E.coli induced septic shock in the rat. Dissertation, Department of Surgery. University of Lund, Malmö General Hospital, MalmöSweden 1991
   Google Scholar
• Tom W W, Dotterrer R M, Villalba M. Steroid effect on capillary permeability in gram-negative septic shock. Arch Surg 1984; 119: 1021–1024
   PubMedGoogle Scholar
• Finlay W E, McKee J. Serum cortisol levels in severely stressed patients. Lancet 1982; 1: 414
   Google Scholar
• Wilson R F. Antithrombin, prekallikrein and fibronectin levels in surgical patients. Arch Surg 1986; 121: 635–640
   PubMedGoogle Scholar
• Gerlach D, Knöll H, Köhler W, Ozegowski J H, Hribalova V. Isolation and characterisation of erythrogenic toxins. V. Identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Hyg I Abt Orig A 1983; 255: 221–233
   PubMedGoogle Scholar
• Kavi J, Wise R. Causes of the haemolytic uraemic syndrome. It might be verocytotoxin produced by Escherichia coli. BMJ 1989; 298: 65–66
   PubMedGoogle Scholar
• Jupin C, Anderson S, Damais C, Alouf J E, Parant M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and interferon. J Exp Med 1988; 167: 752–761
   PubMed Web of Science ®Google Scholar
• Schwartmann W B, Tillotson J R, Taft E G, Wright E. Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med 1979; 300: 1277
   Google Scholar
• Bjorvatn B, Bjertnes L, Fadnes H O, Flaegstad T, Gutteberg T J, Kristiansen B-E, Pape J, Rekvig O P, Østerud B, Aanderud L. Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J 1984; 298: 439–441
   Google Scholar
• Häuser W, Christmann F-J, Klein T, Traut G. Therapeutic plasma exchange in septic shock. Therapeutic plasma exchange and selective plasma separation, R Bambauer, P S Malchesky, D Falkenhagen. Schattauer, Stuttgart, New York 1987; 287–293
   Google Scholar
• Stegmayr B, Berseus O, Björsell-Östling E, Wirell M. Plasma exchange in patients with severe consumption coagulopathy and acute renal failure. Transfus Sci 1990; 11: 271–277
   Google Scholar
• Stegmayr B, Tärnvik A. Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration. Blood Purif 1989; 7: 10–15
   PubMed Web of Science ®Google Scholar